期刊
MUSCLE & NERVE
卷 57, 期 2, 页码 212-216出版社
WILEY
DOI: 10.1002/mus.25653
关键词
amyotrophic lateral sclerosis; CX3CR1 gene; survival; microglia; neurodegeneration
资金
- Italian Ministry of Health (Ricerca Sanitaria Finalizzata) [RF-2010-2309849]
- European Community Health Seventh Framework Programme [278611, 259867]
- Joint Programme-Neurodegenerative Disease Research (Italian Ministry of Education and University Project)
- Joint Programme-Neurodegenerative Disease Research (Sophia Project)
- Joint Programme-Neurodegenerative Disease Research (Strength Project)
- Associazione Piemontese per l'Assistenza alla SLA, Torino, Italy
- Fondazione Mario e Anna Magnetto, Alpignano, Torino
- National Institutes of Health
Introduction: In the brain, the chemokine (C-X3-C motif) receptor 1 (1CX3CR1) gene is expressed only by microglia, where it acts as a key mediator of the neuron-microglia interactions. We assessed whether the 2 common polymorphisms of the CX3CR1 gene (V249I and T280M) modify amyotrophic lateral sclerosis (ALS) phenotype. Methods: The study included 755 ALS patients diagnosed in Piemonte between 2007 and 2012 and 369 age-matched and sex-matched controls, all genotyped with the same chips. Results: Neither of the variants was associated with an increased risk of ALS. Patients with the V249I V/V genotype had a 6-month-shorter survival than those with I/I or V/I genotypes (dominant model, P = 0.018). The T280M genotype showed a significant difference among the 3 genotypes (additive model, P = 0.036). Cox multivariable analysis confirmed these findings. Discussion: We found that common variants of the CX3CR1 gene influence ALS survival. Our data provide further evidence for the role of neuroinflammation in ALS.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据